AnGes MG

AnGes MG serves patients through innovative drugs, particularly those with diseases that have no effective treatment to date. AnGes MG is engaged in the research and development of gene-based medical products. It provides genetic medicines, such as Hepatocyte Growth Factor (HGF) genetic medicine, NF-KB Decoy Oligonucleotides, and non-viral vectors like Japan Enveloped Hemagglutinating Virus (HVJ-E).